We are live on
!
Find out more
EHWM
Eads & Heald Wealth Management Portfolio holdings
AUM
$201M
1-Year Est. Return
21.29%
This Fund
S&P 500
This Quarter
Est. Return
+1.91%
1 Year Est. Return
+21.29%
3 Year Est. Return
+70.18%
5 Year Est. Return
+104.01%
10 Year Est. Return
+364.64%
AUM
$147M
AUM Growth
+$1.46M
(+1%)
Cap. Flow
+$183K
Cap. Flow
% of AUM
0.12%
Top 10 Holdings %
Top 10 Hldgs %
14.79%
Holding
136
New
6
Increased
51
Reduced
68
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$773K |
| 2 |
Ryder
R
|
+$399K |
| 3 |
Vulcan Materials
VMC
|
+$272K |
| 4 |
CELG
Celgene Corp
CELG
|
+$249K |
| 5 |
Kimberly-Clark
KMB
|
+$240K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$751K |
| 2 |
Gilead Sciences
GILD
|
+$353K |
| 3 |
Bath & Body Works
BBWI
|
+$296K |
| 4 |
Toll Brothers
TOL
|
+$245K |
| 5 |
Equifax
EFX
|
+$217K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.06% |
| 2 | Industrials | 15.91% |
| 3 | Technology | 13.91% |
| 4 | Consumer Staples | 12.85% |
| 5 | Consumer Discretionary | 11.14% |
Similar funds
LI
FFL
SWIA
FCM
FIA
SA
FFC
RM
Eads & Heald Wealth Management's Q4 2016 Portfolio in Review
As of Q4 2016, Eads & Heald Wealth Management held 136 positions worth $147M, up 1% from $145M the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Eads & Heald Wealth Management's Q4 2016 filing shows 6 new, 51 increased, 68 reduced and 4 closed positions. Its largest new stake was Vulcan Materials: 2,250 shares worth $282K. The largest sale was Allergan plc, an estimated $751K.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 18% a quarter earlier, followed by Industrials and Technology.
- Eads & Heald Wealth Management's largest Q4 2016 buy was Vulcan Materials: 2,250 shares worth $282K.
- Eads & Heald Wealth Management added most to Meta Platforms (Facebook) in Q4 2016, an estimated $773K increase.
- Eads & Heald Wealth Management's biggest Q4 2016 reduction was Allergan plc, cutting an estimated $751K.
- Eads & Heald Wealth Management fully exited Gilead Sciences in Q4 2016, selling an estimated $353K.
- Eads & Heald Wealth Management's ten largest holdings make up 15% of its $147M portfolio in Q4 2016.
- Eads & Heald Wealth Management opened 6 new positions and closed 4 in Q4 2016.
- Eads & Heald Wealth Management's portfolio value rose 1% quarter-over-quarter to $147M.
Based on Eads & Heald Wealth Management's 13F filing for Q4 2016, filed 13 Feb 2017.